Equities

Ngl Fine Chem Ltd

NGLFINE:NSI

Ngl Fine Chem Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,865.65
  • Today's Change-54.35 / -2.83%
  • Shares traded1.68k
  • 1 Year change-4.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 05:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments553525295
Total Receivables, Net1,068668647
Total Inventory444276597
Prepaid expenses181714
Other current assets, total43141182
Total current assets2,1271,6271,735
Property, plant & equipment, net1,3081,139947
Goodwill, net1.531.531.53
Intangibles, net1.171.733.04
Long term investments464426
Note receivable - long term301413
Other long term assets------
Total assets3,5552,8712,769
LIABILITIES
Accounts payable494246372
Accrued expenses--0.010.02
Notes payable/short-term debt317284234
Current portion long-term debt/capital leases162031
Other current liabilities, total393319
Total current liabilities866583657
Total long term debt7.452134
Total debt340325300
Deferred income tax221419
Minority interest------
Other liabilities, total342827
Total liabilities929645737
SHAREHOLDERS EQUITY
Common stock313131
Additional paid-in capital1.17--1.17
Retained earnings (accumulated deficit)2,5942,1952,000
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2,6262,2252,032
Total liabilities & shareholders' equity3,5552,8712,769
Total common shares outstanding6.186.186.18
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.